1. The World Health Organization (WHO) has announced the recommendations for the viral composition of influenza vaccines for the 2022-2023 northern hemisphere influenza season.

2. The recommendations include specific strains of the influenza virus that should be included in the vaccines.

3. The recommendations are based on influenza virus surveillance data and analysis conducted by an advisory group of experts.

4. The constant evolution of influenza viruses necessitates periodic updates of the strains included in the vaccines to ensure their effectiveness.

5. The recommendations cover both quadrivalent and trivalent vaccines, with specific strains for each type.

6. The recommended strains include H1N1, H3N2, and B lineage viruses.

7. The recommendations apply to both egg-based and cell culture- or recombinant-based vaccines.

8. The recommendations serve as guidance for national vaccine regulatory agencies and pharmaceutical companies in developing, producing, and licensing influenza vaccines for the upcoming season.

9. The announcement was made at the end of a 4-day information meeting on the composition of influenza virus vaccines, which is held twice annually.

10. The recommendations aim to ensure that the vaccines provide protection against the most prevalent strains of influenza viruses anticipated for the upcoming season.